Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.72 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.56 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.44 |
| ▸ | ABCC4 | O15439 | 2/20 | 0.44 |
| ▸ | CACNA1F | O60840 | 2/20 | 0.44 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.44 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.44 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.44 |
| ▸ | SCN1A | P35498 | 2/20 | 0.44 |
| ▸ | HTR2B | P41595 | 2/20 | 0.44 |
| ▸ | CACNA1D | Q01668 | 2/20 | 0.44 |
| ▸ | CACNA1S | Q13698 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29923915 | 0.84 | ALDH1A1 (1.00) | ALDH1A1CYP1A2TSHRNPSR1MAPT | |
| SCHEMBL12788041 | 0.84 | ALDH1A1 (1.00) | ALDH1A1CYP1A2TSHRNPSR1MAPT | |
| SCHEMBL8330910 | 0.84 | ALDH1A1 (0.55) | ALDH1A1CYP1A2TSHRNPSR1MAPT | |
| SCHEMBL2634390 | 0.83 | ALDH1A1 (0.74) | ALDH1A1CYP1A2TSHRNPSR1MAPT | |
| SCHEMBL27379522 | 0.83 | ALDH1A1 (0.97) | ALDH1A1CYP1A2TSHRNPSR1MAPT | |
| SCHEMBL38657948 | 0.83 | ALDH1A1 (0.74) | ALDH1A1CYP1A2TSHRNPSR1MAPT | |
| SCHEMBL2353735 | 0.83 | ALDH1A1 (0.74) | ALDH1A1CYP1A2TSHRNPSR1MAPT | |
| SCHEMBL28254105 | 0.81 | ALDH1A1 (0.72) | ALDH1A1CYP1A2TSHRNPSR1MAPT | |
| SCHEMBL11276948 | 0.81 | KMT2A (0.50) | ALDH1A1TSHRMAPTLMNAKMT2A | |
| SCHEMBL3990265 | 0.80 | CYP1A2 (0.73) | ALDH1A1CYP1A2TSHRMAPTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090305437-A1 | FABRICATION OF INORGANIC MATERIALS USING TEMPLATES WITH LABILE LINKAGE | CAMBRIOS TECHNOLOGIES CORPORATION (US) | 2009-12-10 | — | — | US | disclosed |
| WO-2007103539-A2 | FABRICATION OF INORGANIC MATERIALS USING TEMPLATES WITH LABILE LINKAGE | CAMBRIOS TECHNOLOGIES CORPORATION (US) | 2007-09-13 | — | — | WO | disclosed |
| US-5998580-A | PROVIDING AN AMINO ACID INCLUDING A PHOTOLABILE MOLECULE AND INCORPORATING THE AMINO ACID INTO A PEPTIDE DURING SYNTHESIS, WHEREIN INCORPORATION OF THE AMINO ACID INTO THE PEPTIDE PRODUCES A PHOTOSENSITIVE PEPTIDE | NATIONAL INSTITUTES OF HEALTH, THE | 1999-12-07 | — | — | US | disclosed |
| WO-1997013782-A1 | PHOTOSENSITIVE CAGED MACROMOLECULES | UNIVERSITY OF MASSACHUSETTS MEDICAL CENTER (US) | 1997-04-17 | — | — | WO | disclosed |
| US-5449682-A | Angiotensin II antagonists incorporating a substituted benzyl element | MERCK & CO., INC. (US) | 1995-09-12 | — | — | US | disclosed |
| US-5240938-A | Angiotensin II antagonists incorporating a substituted pyridoimidazolyl ring | MERCK & CO., INC. (US) | 1993-08-31 | — | — | US | disclosed |
| WO-1991011999-A1 | ANGIOTENSIN II ANTAGONISTS INCORPORATING A SUBSTITUTED BENZYL ELEMENT | MERCK & CO., INC. (US) | 1991-08-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090305437-A1 | FABRICATION OF INORGANIC MATERIALS USING TEMPLATES WITH LABILE LINKAGE | ILK, ECPAS, STUB1 | ALDH1A1 3671/4885CYP1A2 4449/4885TSHR 4694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.